Immunai raises $60M because it expands from bettering immune therapies to discovering new ones, too – TechCrunch
Simply three years after its founding, biotech startup Immunai has raised $60 million in Sequence A funding, bringing its whole raised to over $80 million.… Read More »Immunai raises $60M because it expands from bettering immune therapies to discovering new ones, too – TechCrunch
